Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

August 1, 2023; Volume 64,Issue 8
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Tatsumi, Mitsuaki

    1. Initial Evaluation of [<sup>18</sup>F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
      Open Access
      Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
      Tadashi Watabe, Sadahiro Naka, Mitsuaki Tatsumi, Takashi Kamiya, Toru Kimura, Yasushi Shintani, Kaori Abe, Tomohiro Miyake, Kenzo Shimazu, Shogo Kobayashi, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hidenori Inohara, Hiroki Kato, Yuriko Mori, Jens Cardinale and Frederik L. Giesel
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1225-1231; DOI: https://doi.org/10.2967/jnumed.123.265486
  2. Tauber, Robert

    1. Safety and Efficacy of [<sup>177</sup>Lu]-PSMA-I&amp;T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years
      You have access
      Safety and Efficacy of [177Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years
      Robert Tauber, Karina Knorr, Margitta Retz, Isabel Rauscher, Sonia Grigorascu, Kimberley Hansen, Calogero D’Alessandria, Hans-Jürgen Wester, Jürgen Gschwend, Wolfgang Weber, Matthias Eiber and Thomas Langbein
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1244-1251; DOI: https://doi.org/10.2967/jnumed.122.265259
    2. The Impact of PSMA PET–Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy
      You have access
      The Impact of PSMA PET–Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy
      Amir Karimzadeh, Matthias Heck, Robert Tauber, Esteban Solaris, Stephan Nekolla, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1252-1258; DOI: https://doi.org/10.2967/jnumed.122.265346
  3. Thackeray, James T.

    1. Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
      You have access
      Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
      Johanna Diekmann, Jonas Neuser, Manuel Röhrich, Thorsten Derlin, Carolin Zwadlo, Tobias Koenig, Desiree Weiberg, Felix Jäckle, Tibor Kempf, Tobias L. Ross, Jochen Tillmanns, James T. Thackeray, Julian Widder, Uwe Haberkorn, Johann Bauersachs and Frank M. Bengel
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1279-1286; DOI: https://doi.org/10.2967/jnumed.122.265147
  4. Therriault, Joseph

    1. Open Access
      The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
      Arthur C. Macedo, Cécile Tissot, Joseph Therriault, Stijn Servaes, Yi-Ting Wang, Jaime Fernandez-Arias, Nesrine Rahmouni, Firoza Z. Lussier, Marie Vermeiren, Gleb Bezgin, Paolo Vitali, Kok Pin Ng, Eduardo R. Zimmer, Marie-Christine Guiot, Tharick A. Pascoal, Serge Gauthier and Pedro Rosa-Neto
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1171-1178; DOI: https://doi.org/10.2967/jnumed.122.265200
  5. Theurer, Sarah

    1. SUV<sub>max</sub> Above 20 in <sup>18</sup>F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
      You have access
      SUVmax Above 20 in 18F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
      Gregor Zaun, Manuel Weber, Martin Metzenmacher, Marcel Wiesweg, Thomas Hilser, Yasmin Zaun, Sven Liffers, Michael Pogorzelski, Isabel Virchow, Wilfried Eberhardt, Sarah Theurer, Tanja Abu Sabbah, Timm M. Reissig, Martin Stuschke, Cornelius Kürten, Timon Hussain, Stephan Lang, Stefan Kasper, Wolfgang P. Fendler, Ken Herrmann and Martin Schuler
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1191-1194; DOI: https://doi.org/10.2967/jnumed.122.265161
  6. Tillmanns, Jochen

    1. Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
      You have access
      Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
      Johanna Diekmann, Jonas Neuser, Manuel Röhrich, Thorsten Derlin, Carolin Zwadlo, Tobias Koenig, Desiree Weiberg, Felix Jäckle, Tibor Kempf, Tobias L. Ross, Jochen Tillmanns, James T. Thackeray, Julian Widder, Uwe Haberkorn, Johann Bauersachs and Frank M. Bengel
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1279-1286; DOI: https://doi.org/10.2967/jnumed.122.265147
  7. Tissot, Cécile

    1. Open Access
      The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
      Arthur C. Macedo, Cécile Tissot, Joseph Therriault, Stijn Servaes, Yi-Ting Wang, Jaime Fernandez-Arias, Nesrine Rahmouni, Firoza Z. Lussier, Marie Vermeiren, Gleb Bezgin, Paolo Vitali, Kok Pin Ng, Eduardo R. Zimmer, Marie-Christine Guiot, Tharick A. Pascoal, Serge Gauthier and Pedro Rosa-Neto
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1171-1178; DOI: https://doi.org/10.2967/jnumed.122.265200
  8. Tran, Thuy A.

    1. Tumor Characterization by [<sup>68</sup>Ga]FAPI-46 PET/CT Can Improve Treatment Selection for Pancreatic Cancer Patients: An Interim Analysis of a Prospective Clinical Trial
      You have access
      Tumor Characterization by [68Ga]FAPI-46 PET/CT Can Improve Treatment Selection for Pancreatic Cancer Patients: An Interim Analysis of a Prospective Clinical Trial
      Pawel Rasinski, Siri af Burén, Maria Holstensson, Ted Nilsson, Louiza Loizou, Thuy A. Tran, Ernesto Sparrelid, J. Matthias Löhr and Rimma Axelsson
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1232-1237; DOI: https://doi.org/10.2967/jnumed.123.265481
  9. Tuisku, Jouni

    1. Endogenous Opioid Release After Orgasm in Man: A Combined PET/Functional MRI Study
      Open Access
      Endogenous Opioid Release After Orgasm in Man: A Combined PET/Functional MRI Study
      Patrick Jern, Jinglu Chen, Jouni Tuisku, Tiina Saanijoki, Jussi Hirvonen, Lasse Lukkarinen, Sandra Manninen, Semi Helin, Vesa Putkinen and Lauri Nummenmaa
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1310-1313; DOI: https://doi.org/10.2967/jnumed.123.265512
  10. Tupin, John D.

    1. Facial Anonymization and Privacy Concerns in Total-Body PET/CT
      You have access
      Facial Anonymization and Privacy Concerns in Total-Body PET/CT
      Aaron R. Selfridge, Benjamin A. Spencer, Yasser G. Abdelhafez, Keisuke Nakagawa, John D. Tupin and Ramsey D. Badawi
      Journal of Nuclear Medicine August 1, 2023, 64 (8) 1304-1309; DOI: https://doi.org/10.2967/jnumed.122.265280
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 64 (8)
Journal of Nuclear Medicine
Vol. 64, Issue 8
August 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
  • Metformin-Induced Receptor Turnover Alters Antibody Accumulation in HER-Expressing Tumors
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire